Skip to main content
Top
Published in: Indian Journal of Pediatrics 2/2017

01-02-2017 | Original Article

Risk of Intussusception with Rotavirus Vaccine

Authors: Vivekanandan Kalaiselvan, Prasad Thota, Vipin Kumar, Madhvi Singh Rathore, Anusha Thota, Gyanendra Nath Singh

Published in: Indian Journal of Pediatrics | Issue 2/2017

Login to get access

Abstract

Objective

To study the case series for intussusception associated with the vaccination of rotavirus vaccine in children.

Methods

The study of spontaneous adverse event monitoring such as intussusception due to rotavirus vaccine was carried out from the year 2011 through 2015. The individual case safety reports (ICSRs) of this event were collated, assessed and recorded as per the requirement of Suspected Adverse Drug Reactions Reporting form of Pharmacovigilance Programme of India (PvPI).

Results

In the present study, 10 ICSRs of intussussception due to rotavirus vaccine were reported to PvPI. Of which 3 ICSRs were found to be causal relationship with rotavirus vaccine, as evidenced by the adequate information provided in ICSRs.

Conclusions

Since intussusception, the emerging safety as one of the important safety concern, healthcare professionals are advised to monitor and report to the concerned authority for appropriate action.
Literature
1.
go back to reference Kalaiselvan V, Kumar R, Thota P, Tripathi A, Singh GN. Status of documentation grading and completeness score for Indian individual case safety reports. Indian J Pharmacol. 2015;47:325–7.CrossRef Kalaiselvan V, Kumar R, Thota P, Tripathi A, Singh GN. Status of documentation grading and completeness score for Indian individual case safety reports. Indian J Pharmacol. 2015;47:325–7.CrossRef
2.
go back to reference Kalaiselvan V, Tripathi A, Saurabh A, et al. Quantitative methods for identification of signals for individual case safety reports in India. Ther Innov Regul Sci. 2015;49:898–902.CrossRef Kalaiselvan V, Tripathi A, Saurabh A, et al. Quantitative methods for identification of signals for individual case safety reports in India. Ther Innov Regul Sci. 2015;49:898–902.CrossRef
3.
go back to reference Kharb P, Mittal N, Gupta MC. An evaluation of adverse drug reactions monitoring at a pharmacovigilance unit under pharmacovigilance programme of India in a tertiary care hospital of Haryana. Int J Basic Clin Pharmacol. 2015;4:556–60.CrossRef Kharb P, Mittal N, Gupta MC. An evaluation of adverse drug reactions monitoring at a pharmacovigilance unit under pharmacovigilance programme of India in a tertiary care hospital of Haryana. Int J Basic Clin Pharmacol. 2015;4:556–60.CrossRef
4.
go back to reference Kalaiselvan V, Kaur I, Kumar V, Singh GN. Reporting of adverse drug reactions due to cardiovascular drugs in India: a national duty. Indian Heart J. 2015;67:613–5.CrossRefPubMedPubMedCentral Kalaiselvan V, Kaur I, Kumar V, Singh GN. Reporting of adverse drug reactions due to cardiovascular drugs in India: a national duty. Indian Heart J. 2015;67:613–5.CrossRefPubMedPubMedCentral
5.
go back to reference Duclos P, Delo A, Aguado T, et al. Immunization safety priority project at the World Health Organization. Semin Pediatr Infect Dis. 2003;14:233–9.CrossRefPubMed Duclos P, Delo A, Aguado T, et al. Immunization safety priority project at the World Health Organization. Semin Pediatr Infect Dis. 2003;14:233–9.CrossRefPubMed
8.
go back to reference Murphy TV, Gargiullo PM, Massoudi MS, et al; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–72. Murphy TV, Gargiullo PM, Massoudi MS, et al; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–72.
9.
go back to reference Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22.
11.
go back to reference Carlin BJ, Macartney K, Lee KJ, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clin Infect Dis. 2013;57:1427–34.CrossRefPubMed Carlin BJ, Macartney K, Lee KJ, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clin Infect Dis. 2013;57:1427–34.CrossRefPubMed
12.
go back to reference Whittaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatics: the self-controlled case series method. Stat Med. 2006;25:1768–97.CrossRef Whittaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatics: the self-controlled case series method. Stat Med. 2006;25:1768–97.CrossRef
Metadata
Title
Risk of Intussusception with Rotavirus Vaccine
Authors
Vivekanandan Kalaiselvan
Prasad Thota
Vipin Kumar
Madhvi Singh Rathore
Anusha Thota
Gyanendra Nath Singh
Publication date
01-02-2017
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 2/2017
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-016-2230-z

Other articles of this Issue 2/2017

Indian Journal of Pediatrics 2/2017 Go to the issue